Pii Starts Facility Expansion for Aseptic Manufacturing

Pharmaceutics International, Inc. has begun construction of a new cGMP aseptic fill/finish manufacturing facility.

Pharmaceutics International, Inc. (Pii), a privately held contract development and manufacturing company,  has begun construction of a new 24,000-sq.-ft. cGMP aseptic fill/finish manufacturing facility, expanding the company’s Hunt Valley, MD campus to meet current client projects with near-term commercial manufacturing needs and demand for larger batch sizes.

The new facility will more than double the company's current sterile GMP manufacture capacity. Fill/finish suites will include automated vial and syringe filling, inspection and labeling equipment capable of producing batch sizes of 100,000 plus units.

The expansion follows a recent FDA pre-approval inspection (PAI), allowing the company to commercially manufacture an aseptic vial in its existing Hunt Valley aseptic f